跳至主要内容
临床试验/NCT00302302
NCT00302302已完成1 期

The Effects of Increasing Doses of L-arabinose in a Sucrose Rich Meal on Intestinal Sucrase Activity in Man

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2005年9月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
15
试验地点
2
主要终点
Plasma glucose, insulin, triglycerides, GIP and GLP-1

研究概览

简要总结

The purpose of this study is to investigate the effect of L-arabinose in a sugar-rich meal on intestinal sucrase activity in healthy volunteers by measuring postprandial blood glucose and insulin, and selected intestinal hormonal responses to increasing doses of L-arabinose.

详细描述

Background:

The intake of common table sugar (sucrose) in the industrialised countries is relatively high. In Denmark the daily intake of sugar is in the range of 30-40 g/d exclusive the intake of sugar containing drinks. The health consequences of this relatively high sugar intake are heavily debated in the media. One of the arguments is that a high sugar intake may be one of the factors involved in the development of the metabolic syndrome, including overweight, increased blood glucose and insulin levels as well as impaired insulin action.

L-arabinose is widely distributed in plants and is a common component in plant cell walls in maize, wheat, rye, rice, plant gums etc. The isolated 5-carbon sugar has been shown to suppress the increase of blood glucose and plasma insulin after ingestion of sucrose in rats by inhibition of sucrase activity. In vitro studies on Caco-2 cells indicate that L-arabinose is a potent inhibitor on sucrase activity, possibly in a non-competitive way.

Potential nutritional advantages of consuming L-arabinose in combination with sucrose may therefore be a delayed digestion of sucrose and a lower absorption of glucose, resulting in both lower blood glucose and insulin levels. A delayed digestion of sucrose will reduce the energy utilisation with the potential of reducing weight gain in human subjects.

Methods:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • healthy males
  • BMI between 18.4-25 kg/m2
  • age between 18 and 30

排除标准

  • donation of blood 3 months before or during the study
  • gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic infectious disease (HIV or hepatitis)
  • consumption of more than 21 alcoholic drinks/week
  • elite athletes
  • on medication

结局指标

主要结局

Plasma glucose, insulin, triglycerides, GIP and GLP-1

时间窗: 2 hours

Blood samples 2 hours after a test meal

次要结局

  • Appetite measurements and energy intake(10 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jens Rikardt Andersen

Associate Professor

University of Copenhagen

研究点 (2)

Loading locations...

相似试验

The Effects of L-arabinose on Intestinal Sucrase... | 临床试验